AI Article Synopsis

  • Nemolizumab is a monoclonal antibody designed to treat atopic dermatitis by targeting the interleukin-31 receptor A, effectively reducing itching (pruritus).
  • The study aimed to optimize dosing regimens for nemolizumab, using population modeling from 299 patients who received varying doses either every 4 weeks or every 8 weeks.
  • Simulations indicated that a flat dose regimen around 75 mg every 4 weeks could be as effective as doses within the 0.5 to 2 mg/kg range, supporting further dose optimization in clinical trials.

Article Abstract

Nemolizumab is a humanized anti-interleukin-31 receptor A monoclonal antibody for treating atopic dermatitis, and it especially improves pruritus. The objective of the simulation study was to optimize the dose regimen using a flat dose. The serum nemolizumab concentration and pruritus visual analog scale as an efficacy end point were modeled using the population analysis approach in 299 patients with atopic dermatitis who received placebo or doses between 0.1 and 3 mg/kg as a single dose once every 4 weeks or 2 mg/kg once every 8 weeks. A 1-compartment model with first-order absorption was employed as the pharmacokinetic model. An indirect turnover model with an inhibition component was employed as the main part of the pharmacokinetic-pharmacodynamic model. The models well described the observations. Therefore, simulations with several dose regimens were performed to optimize the dose regimen including a flat dose. The simulated area under the concentration-time curve at a steady state around 75 mg in the every-4-week regimen corresponds to that associated with the dose range of 0.5 to 2 mg/kg in the 4-week regimen. The simulated pruritus visual analog scale also showed a similar tendency. These simulation results support dose optimization during the clinical development program of nemolizumab.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.969DOI Listing

Publication Analysis

Top Keywords

atopic dermatitis
8
dose
8
optimize dose
8
dose regimen
8
flat dose
8
pruritus visual
8
visual analog
8
analog scale
8
dosage optimization
4
nemolizumab
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!